跳至主要内容
临床试验/NCT02245724
NCT02245724撤回1 期

Stem Cell Therapy in Mental Retardation

Neurogen Brain and Spine Institute1 个研究点 分布在 1 个国家开始时间: 2011年9月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
撤回
试验地点
1
主要终点
Change in common clinical symptoms of mental retardation

研究概览

简要总结

The purpose of this study was to analyze the benefit of autologous mononuclear cell therapy in mental retardation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Months 至 40 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosed cases of mental retardation
  • age above 6 months

排除标准

  • presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus
  • malignancies
  • bleeding tendencies
  • pneumonia
  • renal failure
  • severe liver dysfunction
  • severe anemia [Hemoglobin < 8]
  • any bone marrow disorder
  • space occupying lesion in brain
  • other acute medical conditions such as respiratory infection and pyrexia

研究组 & 干预措施

Stem Cell

Experimental

Bone marrow mononuclear cell transplantation

干预措施: Stem Cell (Biological)

结局指标

主要结局

Change in common clinical symptoms of mental retardation

时间窗: 1 year

Change in symptoms such as cognition, remote memory, problem solving,understanding of relationships,social interaction,communication,self care, activities of daily living will be recorded at 1 year follow up.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验